Taipei Exchange - Delayed Quote TWD

BioGend Therapeutics Co., Ltd. (6733.TWO)

Compare
33.00
0.00
(0.00%)
At close: 1:30:07 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
156,644.00
109,908.00
31,446.00
9,269.00
1,393.00
Cost of Revenue
30,487.00
20,290.00
8,667.00
6,210.00
662.00
Gross Profit
126,157.00
89,618.00
22,779.00
3,059.00
731.00
Operating Expense
265,098.00
266,159.00
241,992.00
167,368.00
134,346.00
Operating Income
-138,941.00
-176,541.00
-219,213.00
-164,309.00
-133,615.00
Net Non Operating Interest Income Expense
6,264.00
6,662.00
4,502.00
2,865.00
2,343.00
Pretax Income
-135,042.00
-169,222.00
-213,895.00
-144,267.00
-145,594.00
Tax Provision
-8,304.00
-8,304.00
-8,396.00
--
--
Net Income Common Stockholders
-109,933.00
-156,325.00
-184,455.00
-138,485.00
-145,594.00
Diluted NI Available to Com Stockholders
-109,933.00
-156,325.00
-184,455.00
-138,485.00
-145,594.00
Basic EPS
-0.89
-1.30
-1.79
-1.37
-1.65
Diluted EPS
-0.89
-1.30
-1.79
-1.37
-1.65
Basic Average Shares
123,070.59
120,282.00
103,076.00
101,281.00
88,537.75
Diluted Average Shares
123,070.59
120,282.00
103,076.00
101,281.00
88,537.75
Total Expenses
295,585.00
286,449.00
250,659.00
173,578.00
135,008.00
Net Income from Continuing & Discontinued Operation
-109,933.00
-156,325.00
-184,455.00
-138,485.00
-145,594.00
Normalized Income
-109,933.00
-156,325.00
-184,455.00
-138,485.00
-145,594.00
Interest Income
6,497.00
6,924.00
4,593.00
2,883.00
2,348.00
Interest Expense
233.00
262.00
91.00
18.00
5.00
Net Interest Income
6,264.00
6,662.00
4,502.00
2,865.00
2,343.00
EBIT
-134,809.00
-168,960.00
-213,804.00
-144,249.00
-145,589.00
EBITDA
-80,658.00
-113,944.00
-160,620.00
-116,055.00
-126,395.00
Reconciled Cost of Revenue
30,487.00
20,290.00
8,667.00
6,210.00
662.00
Reconciled Depreciation
54,151.00
55,016.00
53,184.00
28,194.00
19,194.00
Net Income from Continuing Operation Net Minority Interest
-109,933.00
-156,325.00
-184,455.00
-138,485.00
-145,594.00
Normalized EBITDA
-80,658.00
-113,944.00
-160,620.00
-116,055.00
-126,395.00
Tax Rate for Calcs
0.00
0.00
0.00
--
--
12/31/2020 - 6/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4726.TWO Mycenax Biotech Inc.
40.25
0.00%
 
6712.TWO Ever Supreme Bio Technology Co., Ltd
175.50
-0.28%
 
4168.TWO GlycoNex Incorporation
24.00
0.00%
 
6461.TWO Intech Biopharm Corporation
24.85
+0.20%
 
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
92.10
+0.33%
 
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
 
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
 
6662.TWO BioLASCO Taiwan Co., Ltd.
33.00
-0.30%
 
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%